You are here >> Home > Latest Updates > Pelvic Cancer > Outcomes After…
For women with advanced or recurring gynecologic cancers—such as cervical, vaginal, vulvar, or endometrial cancer—doctors may recommend a major surgery called pelvic exenteration. This procedure removes several organs in the pelvis to try and control the cancer. It’s a big operation, and a new international study offers important insights into what patients can expect afterward.
The study followed 862 women who had this surgery between 2005 and 2023. Most had the operation with the goal of curing the cancer. Five years later, about 44% were still cancer-free. Survival depended on several key factors.
Women were more likely to do well if:
⦿ All the cancer was removed during surgery.
⦿ They had lymph node surgery.
⦿ The cancer had not spread to distant lymph nodes.
⦿ The surgery was done for a returning cancer, not persistent disease after earlier treatment.
The biggest risks for cancer coming back or shorter survival were:
⦿ Cancer cells left at the edges of the removed tissue.
⦿ Cancer in blood vessels or lymph channels.
⦿ Needing a more extensive total pelvic exenteration.
Doctors used this data to build a new scoring system that can help estimate individual risk and guide follow-up care.
If you’re facing pelvic exenteration, this research can help guide honest conversations about recovery, risks, and long-term outcomes.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
